Changing Public Perception of the Pharmaceutical Industry


Applied Clinical Trials

2004, Merck voluntarily withdraws its COX-2 selective nonsteroidal anti-inflammatory drug for the treatment of pain. This event affected the industry’s image and increased political, public, and industry focus on product safety and risk management.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.